多响应性微囊用于预防子宫内粘附
Jing Wang1,2, Qiong Chen1, Yueyue Wang1
1Department of Obstetrics and Gynecology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China.
ACS nano
|February 6, 2025
概括
研究人员开发了多反应性微囊来治疗子宫内粘附 (IUA). 这些A/G-Fe3O4-Se微囊在治疗受损子宫内膜和改善IUA模型中的怀孕率方面表现有前途.
科学领域:
- 生物材料科学 生物材料科学
- 生殖医学 生殖医学
- 纳米技术纳米技术
背景情况:
- 宫内粘附 (IUA) 对妇女的生殖健康产生负面影响.
- 开发具有增强稳定性和功能的先进生物材料对于IUA预防至关重要.
- 目前的策略需要改进,以有效修复子宫内膜和预防粘附.
研究的目的:
- 开发和评估一种多反应性微囊 (A/G-Fe3O4-Se),用于预防子宫内粘附 (IUA).
- 研究这些微囊在促进子宫内膜再生和改善生殖结果方面的治疗潜力.
主要方法:
- 使用微流体技术制造A/G-Fe3O4-Se微囊,采用酸盐 (ALG) 和凝甲基 (GelMA) 水凝外.
- 装载磁纳米粒子 (Fe3O4-Se) 和一个超声响应的脱 pentane 核心.
- 在体外评估微囊的特性,包括抗氧化,抗菌和治疗效果.
- 在IUA老鼠模型中的体内评估,以评估子宫内膜再生,氧化应激,子宫内膜受容性和怀孕率.
主要成果:
- 这些A/G-Fe3O4-Se微囊显示出来自ALG和GelMA的生物友好特性.
- 封装的磁反应性Fe3O4-Se促进了子宫内的适应性分布.
- 在体外研究证实了抗氧化,抗菌和治疗性质.
- 在体内研究表明,IUA大鼠模型中氧化应激减少,子宫内膜再生增强,受体能力提高,怀孕率增加.
结论:
- A/G-Fe3O4-Se微囊代表了治疗受损子宫内膜和预防IUA的有希望的策略.
- 这些微囊的多反应性和多方面的功能提供了显著的治疗潜力.
- 这种生物材料方法有望改善女性受IUA影响的生殖健康结果.
更多相关视频
相关概念视频
Adhesion
37.0K
Adhesion occurs when one type of molecule is attracted to a different molecule. Water exhibits adhesive properties in the presence of polar surfaces, such as glass or cellulose in plants. For instance, when water is poured into a glass, the positively charged hydrogen molecules of water are more attracted to the negatively charged oxygen molecules in the silica than to the oxygen in neighboring water molecules.
Capillary action is a result of water’s adhesive tendencies. When a narrow...
Capillary action is a result of water’s adhesive tendencies. When a narrow...
37.0K
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
332
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
332
Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160
Intrauterine Drug Delivery Systems
168
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
168


